logo
Top Stories
56
45
volkswagen-112017-lg.jpg

Volkswagen plans to invest about 22.8 billion euros in its core brand from 2018 to 2022, with main focus on e-mobility and modularization. In a statement on Saturday, the German automaker announced that the investments, as part of the brand's Transform...

Colcap, the benchmark index of the Colombian stock market, was up 0.09% at the end of Monday's session at 1.444,87 points, boosted by an increase in Bancolombia and Nutresa's shares. Ecopetrol's price decline, however, limited the index rise. Marcela...

Trump-Mic-112017-lg.jpg

Following his twelve-day trip to Asia, President Donald Trump announced Monday the U.S. is putting North Korea back on a list of state sponsors of terrorism. Trump announced the move in comments to reporters ahead of a Cabinet meeting and said his...

Asianmarkets-112014_20Nov17-lg.jpg

Asian stock markets are mostly higher on Tuesday, as the overnight gains on Wall Street as well as upbeat economic data from Germany and the U.S. helped investors shrug off worries over political uncertainty in Germany.

BrunoMars-112017-lg.jpg

Bruno Mars emerged as the champion of the evening at the 2017 American Music Awards Sunday, winning seven prizes, including the coveted "Artist of the Year" award, beating out the likes of Ed Sheeran and Drake. Keith Urban took home three awards, dominating...

AbilifyMyCite-FDA-111417.jpg Schizophrenia drug Abilify MyCite becomes the first drug approved in the U.S. with a sensor that digitally tracks if patients have ingested their medication. The U.S. Food and Drug Administration on Monday approved Abilify MyCite (aripiprazole tablets with sensor), developed by Otsuka Pharmaceutical Co., Ltd. In Japan, Otsuka Holdings' shares were gaining around 2.7 percent
stocklower-111417.jpg European stocks are set to open lower on Tuesday as Chinese economic data disappointed and investors waited for any signs of compromise on U.S. tax policy. Asian stock markets are trading mostly lower after a deluge of Chinese data showed growth in...
Pharma-111417.jpg Today's Daily Dose brings you news about expanded FDA approval for Allergan's schizophrenia drug; post-hoc analysis of Lilly's EMPA-REG OUTCOME trial; Court ruling against MediWound; extension of FDA's decision deadline by 3 months on Theratechnologies' biologics license application, TRACON's phase I data and Zymeworks' deal with Janssen Biotech.
stocklower-111017.jpg Asian stocks gave up early gains to end mostly lower on Tuesday as Chinese economic data disappointed and uncertainty lingered over U.S. tax policy. China's Shanghai Composite index dropped 18.29 points or 0.53 percent to 3,429.55 after a slew of...
More
Trump-Mic-112017.jpg Following his twelve-day trip to Asia, President Donald Trump announced Monday the U.S. is putting North Korea back on a list of state sponsors of terrorism. Trump announced the move in comments ahead of a Cabinet meeting and said his administration would also be ramping up sanctions on North Korea.
More
SenatorAlFranken-112017.jpg A second woman has accused Senator Al Franken, D-Minn., of sexual misconduct, telling CNN the former comedian inappropriately touched her while taking a photo at the Minnesota State Fair. Lindsay Menz claims Franken grabbed her buttocks at the event in the summer of 2010.
More
BillGates-CuringAlzheimers-111317.jpg
Billionaire and Microsoft co-founder Bill Gates is making a personal investment of $50 million into the Dementia Discovery Fund, a venture capital fund that invests in projects and companies to develop treatments for the brain-wasting disease. The investment is not part of Gates' philanthropic Bill & Melinda Gates Foundation, which has focused primarily on infectious diseases.
More
Indian shares may open a tad higher on Tuesday, tracking firm global markets as global growth optimism prevailed. Asian stock markets are broadly higher this morning as strong data from Germany and the U.S. helped investors shrug off worries over the German coalition impasse. Rising bond yields...
volkswagen-112017.jpg
Volkswagen plans to invest about 22.8 billion euros in its core brand from 2018 to 2022, with main focus on e-mobility and modularization. In a statement on Saturday, the German automaker announced that the investments, as part of the brand's Transform 2025+ strategy, will significantly boost the brand's largest product and technology offensive.
More
Today's Daily Dose brings you news about Aerie's progress in phase II trial of glaucoma drug in Japan; phase III results of Egalet's pain pill; FDA approval of GlaxoSmithKline's COPD drug; expanded labeling for Pfizer's kidney cancer drug Sutent and Roche's double blessing on Thursday. More
The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of November 20, 2017. More
Zimbabwe's leader Robert Mugabe has vowed to stay in power for several weeks, despite intensifying pressure on him to stand down, according to reports. In a live TV address, Mr Mugabe said he would preside over the ruling party's congress in December. The...
More
HealthIQ-111517.jpg Health IQ Insurance Services, a startup focused on providing life insurance for health-conscious individuals, said it has secured $34.6 million in Series C funding, led by Andreessen Horowitz. To date, the company has raised a total of $81 million in funding mostly from its existing investors.
More
Follow RTT
Economic Calendar
DateIndicatorPeriodCountry
11/21/17 Monetary Policy Meeting- South Africa
11/21/17 Capital Account Balance - BoPSEP Portugal
11/21/17 Current Account Balance - BoPSEP Portugal
11/21/17 Financial Account Balance - BoPSEP Portugal
11/21/17 ExportsSEP Spain
11/21/17 ImportsSEP Spain
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
02/14/18AMAG, AMAGMakena subcutaneous auto-injector (sNDA)FDA decision on subcutaneous version of Makena to reduce the risk of preterm birth
01/24/18SGYPTRULANCE (sNDA)FDA decision on TRULANCE for the treatment of adults with irritable bowel syndrome with constipation
01/12/18LGNDLUXTURNA (BLA)FDA decision on LUXTURNA for inherited retinal disease
01/12/18ONCELUXTURNA (BLA)FDA decision on LUXTURNA for treatment of patients with vision loss due to confirmed biallelic RPE65 mutation-associated retinal dystrophy.
01/10/18LLYAbemaciclib (NDA)FDA decision on Abemaciclib for the treatment of advanced breast cancer
Complete FDA Calendar
>>
More